107 related articles for article (PubMed ID: 8204442)
1. Effects of 1,25-dihydroxyvitamin D3 and retinoic acid on the proliferation and cell cycle phase distribution of neuroblastoma SK-N-SH cells.
Goplen DP; Brackman D; Aksnes L
Pediatr Hematol Oncol; 1994; 11(2):173-9. PubMed ID: 8204442
[TBL] [Abstract][Full Text] [Related]
2. Role of 1,25-dihydroxyvitamin D3 and extracellular calcium in the regulation of proliferation in cultured SH-SY5Y human neuroblastoma cells.
Celli A; Treves C; Nassi P; Stio M
Neurochem Res; 1999 May; 24(5):691-8. PubMed ID: 10344599
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D receptor in SH-SY5Y human neuroblastoma cells and effect of 1,25-dihydroxyvitamin D3 on cellular proliferation.
Celli A; Treves C; Stio M
Neurochem Int; 1999 Feb; 34(2):117-24. PubMed ID: 10213069
[TBL] [Abstract][Full Text] [Related]
4. Carnosic acid and promotion of monocytic differentiation of HL60-G cells initiated by other agents.
Danilenko M; Wang X; Studzinski GP
J Natl Cancer Inst; 2001 Aug; 93(16):1224-33. PubMed ID: 11504768
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative responses to two human colon cancer cell lines to vitamin D3 are differently modified by 9-cis-retinoic acid.
Kane KF; Langman MJ; Williams GR
Cancer Res; 1996 Feb; 56(3):623-32. PubMed ID: 8564982
[TBL] [Abstract][Full Text] [Related]
6. Regulation of renal parathyroid hormone receptor expression by 1, 25-dihydroxyvitamin D3 and retinoic acid.
Sneddon WB; Barry EL; Coutermarsh BA; Gesek FA; Liu F; Friedman PA
Cell Physiol Biochem; 1998; 8(5):261-77. PubMed ID: 9792954
[TBL] [Abstract][Full Text] [Related]
7. 1,25-dihydroxyvitamin D3 and retonic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects.
Wang Q; Lee D; Sysounthone V; Chandraratna RAS ; Christakos S; Korah R; Wieder R
Breast Cancer Res Treat; 2001 May; 67(2):157-68. PubMed ID: 11519864
[TBL] [Abstract][Full Text] [Related]
8. The effects of sodium butyrate on the retinoic acid-induced changes in 1,25-dihydroxyvitamin D3 receptors in tumorigenic and nontumorigenic bone derived cell lines.
Lee KL; Petkovich PM; Heersche JN
Endocrinology; 1988 Jun; 122(6):2399-406. PubMed ID: 2836162
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid acts synergistically with 1,25-dihydroxyvitamin D3 or antioestrogen to inhibit T-47D human breast cancer cell proliferation.
Koga M; Sutherland RL
J Steroid Biochem Mol Biol; 1991 Oct; 39(4A):455-60. PubMed ID: 1654997
[TBL] [Abstract][Full Text] [Related]
10. Effects of 1,25-dihydroxyvitamin D3 on cell-cycle kinetics of T 47D human breast cancer cells.
Eisman JA; Sutherland RL; McMenemy ML; Fragonas JC; Musgrove EA; Pang GY
J Cell Physiol; 1989 Mar; 138(3):611-6. PubMed ID: 2925799
[TBL] [Abstract][Full Text] [Related]
11. Alternative differentiation of human promyelocytic leukemia cells (HL-60) induced selectively by retinoic acid and 1 alpha,25-dihydroxyvitamin D3.
Miyaura C; Abe E; Suda T; Kuroki T
Cancer Res; 1985 Sep; 45(9):4244-8. PubMed ID: 2992776
[TBL] [Abstract][Full Text] [Related]
12. 1,25-Dihydroxyvitamin D3, but not retinoic acid, induces the differentiation of U937 cells.
Bhalla AK; Williams MM; Lal S; Lydyard PM
Clin Exp Immunol; 1989 May; 76(2):274-7. PubMed ID: 2758696
[TBL] [Abstract][Full Text] [Related]
13. Effect of 20-epi-1alpha,25-dihydroxyvitamin D3 on the proliferation of human neuroblastoma: role of cell cycle regulators and the Myc-Id2 pathway.
Gumireddy K; Ikegaki N; Phillips PC; Sutton LN; Reddy CD
Biochem Pharmacol; 2003 Jun; 65(12):1943-55. PubMed ID: 12787874
[TBL] [Abstract][Full Text] [Related]
14. Induction of anchorage-independent growth of JB6 mouse epidermal cells by 1 alpha,25-dihydroxyvitamin D3.
Hosoi J; Abe E; Suda T; Colburn NH; Kuroki T
Cancer Res; 1986 Nov; 46(11):5582-6. PubMed ID: 3019530
[TBL] [Abstract][Full Text] [Related]
15. Regulation of melanin synthesis of B16 mouse melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid.
Hosoi J; Abe E; Suda T; Kuroki T
Cancer Res; 1985 Apr; 45(4):1474-8. PubMed ID: 2983883
[TBL] [Abstract][Full Text] [Related]
16. Effects of 1,25-dihydroxyvitamin D3 on growth of mouse neuroblastoma cells.
Veenstra TD; Londowski JM; Windebank AJ; Brimijoin S; Kumar R
Brain Res Dev Brain Res; 1997 Mar; 99(1):53-60. PubMed ID: 9088565
[TBL] [Abstract][Full Text] [Related]
17. All-trans retinoic acid blocks the antiproliferative prodifferentiating actions of 1,25-dihydroxyvitamin D3 in normal human keratinocytes.
Gibson DF; Bikle DD; Harris J
J Cell Physiol; 1998 Jan; 174(1):1-8. PubMed ID: 9397150
[TBL] [Abstract][Full Text] [Related]
18. Dibutyryl cAMP enhances the effect of 1,25-dihydroxyvitamin D3 on a human promyelocytic leukemia cell, HL-60, at both the receptor and the postreceptor steps.
Inaba M; Okuno S; Koyama H; Nishizawa Y; Morii H
Arch Biochem Biophys; 1992 Feb; 293(1):181-6. PubMed ID: 1309983
[TBL] [Abstract][Full Text] [Related]
19. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
[TBL] [Abstract][Full Text] [Related]
20. Modulation by retinoic acid of 1,25-dihydroxyvitamin D3 effects on alkaline phosphatase activity and parathyroid hormone responsiveness in an osteoblast-like osteosarcoma cell line.
Grigoriadis AE; Petkovich PM; Rosenthal EE; Heersche JN
Endocrinology; 1986 Aug; 119(2):932-9. PubMed ID: 3015560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
